Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Jun;56(6):1436-41.
doi: 10.1128/iai.56.6.1436-1441.1988.

Natural killer cell activation and interferon production by peripheral blood lymphocytes after exposure to bacteria

G R Klimpel  1 , D W Niesel, M Asuncion, K D Klimpel
Affiliations

Natural killer cell activation and interferon production by peripheral blood lymphocytes after exposure to bacteria

G R Klimpel et al. Infect Immun. 1988 Jun.

Abstract

We have previously shown that peripheral blood natural killer (NK) cells have significant levels of cytotoxic activity against Shigella flexneri-infected HeLa cells. In this report, we show that NK cell activity against K562 tumor cells and Shigella flexneri-infected HeLa cells can be greatly enhanced by preincubating peripheral blood lymphocytes (PBL) for 18 h with kanamycin-treated Shigella flexneri or Salmonella typhimurium. Cell-free supernatants obtained from PBL-bacteria cultures contained high levels of interferon (IFN) activity, which was characterized as a mixture of IFN-gamma and IFN-alpha. Cytotoxic activity associated with PBL precultured with shigellae was associated with predominantly CD16+ (Leu-11+) and CD2+ (OKT-11+) cells. Further, IFN production was dependent upon the presence of CD16+ and CD2+ cells at culture initiation. Enhancement of cytotoxic activity associated with PBL-bacteria cultures did not, however, appear to be dependent upon IFN production, since low numbers of bacteria which failed to stimulate IFN production induced high levels of NK cell activity. Lipopolysaccharide appeared not to be involved in bacteria-induced IFN production or enhanced NK cell activity, since Salmonella lipopolysaccharide failed to induce IFN production or enhance NK cell activity. These results suggest that IFN production by NK cells and the killing of bacteria-infected cells play an important role in host defense against facultative intracellular bacterial infections.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Proc Soc Exp Biol Med. 1966 Jun;122(2):417-21 - PubMed
    1. J Immunol. 1987 Jun 1;138(11):3949-53 - PubMed
    1. J Exp Med. 1969 May 1;129(5):973-92 - PubMed
    1. Arch Intern Med. 1970 Jul;126(1):69-77 - PubMed
    1. Infect Immun. 1979 Oct;26(1):248-53 - PubMed

Publication types

MeSH terms

LinkOut - more resources